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Background
BOLD CMR is a non-contrast approach for examining
myocardial perfusion but despite major technical advance-
ments to date, its reliability remains weak. A key reason
for this is the unpredictable cardiac motion during stress,
which can lead to pronounced artifacts that confound/
mask the true BOLD signal changes during hyperemia.
Recently, regadenoson has become the vasodilator of
choice owing to greater patient tolerability and ease of use.
We hypothesized that at 10-mins post regadenoson
administration (p.r.a), (a) BOLD CMR artifacts at stress
are markedly reduced compared to those conventionally
acquired at 2-mins p.r.a; and (b) that myocardial perfusion
reserve (MPR) remains greater than 2.0 and is highly
correlated with the BOLD effects estimated from T2 maps.
Methods
Canines (n = 7) were studied in a PET/MR system. MR
acquisitions were used to generate short-axis 2D T2 maps;
and the PET acquisitions following 13N-ammonia infusion
were used to quantify myocardial blood flow (MBF). Initi-
ally, 2D T2 maps and PET signals were acquired at rest.
Subsequently, regadenoson (2.5 μg/kg) was administrated.
T2 maps were acquired at 2- and 10-mins p.r.a and PET
signals were acquired at 10-mins p.r.a. Standard deviation
(s) of myocardial T2 values was measured at rest, 2- and
10-mins p.r.a from T2 maps and were used to determine
Myocardial BOLD Variability (MBV, defined as sT2
(stress)/sT2(rest)) at 2- and 10-min p.r.a. Similarly, using
the mean T2 values, Myocardial BOLD Response (MBR,
defined as T2(stress)/T2(rest)) was computed at 10-mins p.
r.a. PET images were analyzed with qPET software to
determine MBF and MPR at rest and 10-mins p.r.a and
were regressed against MBR
Results
A box-plot of observed MBV at 2- and 10-mins p.r.a (and
at rest, for reference), along with representative T2 maps
are shown in Fig. 1. Note the extensive artifacts present in
the T2 map at 2 min, which are absent in the T2 maps
acquired at rest and 10-mins p.r.a. MBV was significantly
larger at 2-mins p.r.a (1.6 ± 0.9) compared to 10-mins p.r.
a (1.0 ± 0.3) and rest (1.0); p < 0.05 for both. Representa-
tive MBF at rest and 10-mins p.r.a are shown in Fig. 2A.
MBF at 10-min p.r.a (1.8 ± 0.9 ml/g/min) was significantly
higher than at rest (0.6 ± 0.3 ml/g/min), p < 0.05 (Fig. 2B).
Mean MPR at 10-min p.r.a was 3.0. Corresponding BOLD
images (T2 maps) are shown in Fig. 2C. Myocardial T2 at
10-min p.r.a (40.4 ± 1.7 ms) was significantly higher than
at rest (37.1 ± 2.0 ms), p < 0.05 (Fig. 2D). MBR was
strongly correlated with MPR (R = 0.7, p < 0.05, Fig. 2E)
Conclusions
Myocardial BOLD images acquired at 10-min p.r.a (com-
pared to 2-min p.r.a) can be free of image artifacts. MPR
at 10-mins p.r.a can be consistently higher than 2.0 and is
strongly correlated with MBR. These data support that
delayed acquisition of BOLD CMR post regadenoson
administration is a viable means for increasing the reliabil-
ity of cardiac BOLD. The clinical utility of this approach
remains to be evaluated in human subjects.
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Figure 1 Myocardial BOLD Variability at Stress Relative to Rest. Box-plot of Myocardial BOLD Variability (sT2 (stress) / sT2 (rest)) computed
from T2 maps acquired at 2 min and 10 min post regadenoson administration (p.r.a) is shown. The mean and range of Myocardial BOLD
Variability are shown under various conditions. Large Myocardial BOLD Variability is observed at 2 mins p.r.a. compared to rest and is markedly
reduced at 10 mins p.r.a. Representative images acquired at the various conditions are shown for reference. Note the marked T2 inhomogeneity
in T2 image at 2 min p.r.a compared to rest and 10 min p.r.a. sT2 denotes the standard deviation of myocardial T2.
Figure 2 13N-Ammonia PET Myocardial Blood Flow and BOLD Response at 10 mins post regadenoson administration (p.r.a.).
Representative rest and stress (10 mins p.r.a) short-axis PET Myocardial Blood Flow (MBF) and myocardial BOLD T2 pages are shown in panels A
and C. Both PET and BOLD images shown significant increase in MBF and BOLD response, respectively, at 10 mins p.r.a. compared to rest. Box
plot of rest and stress MBF and myocardial T2 across all animals are shown in panels B and D, respectively. Mean increase in MBF by a factor of
3.0 and a 9% T2 elevation were observed on the PET and T2 maps acquired at 20 min p.r.a. relative to rest. Results from regression analysis
showed good correlation between PET myocardial perfusion reserve (MBF(stress)/MBF(rest)) and Myocardial BOLD Response (R = 0.7, p < 0.05;
panel E).
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